NCT01204086.

Trial name or title	NCT01204086.
Methods	Six‐week open‐label, randomised trial
Participants	Patients fulfilling DSM‐IV criteria for Major Depression Disorder, with a score of at least 16 on the Hamilton Depression Rating Scale (HDRS). Age range: 16‐65 years old. Exclusion criteria: monoamine oxidase inhibitor or antidepressant treatment within two weeks prior to entering the study, diagnosis of substance abuse within the past three months, an organic mental disease, mental retardation or dementia, a serious surgical condition or physical illness, pregnancy, breastfeeding.
Interventions	Fluoxetine range dose: 20‐80 mg Venlafaxine range dose 75‐ 225 mg
Outcomes	HDRS
Starting date	March 2007
Contact information	Po See Chen, MD, +886‐6‐2353535 ext 5213, chenps@mail.ncku.edu.tw
Notes	Funding: by academy